Related content

Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics

By Ringberg A.   Anagnostaki L.   Anderson H.   Idvall I.   Ferno M.   for the South Sweden Breast Cancer Group  

European Journal of Cancer, Vol. 37, Iss. 12, 2001-08 ,pp. : 1514-1522

Elsevier

Access to resources Recommend Favorite

Ductal Carcinoma In Situ: Risk Factors and Impact of Screening

By Virnig Beth A.   Wang Shi-Yi   Shamilyan Tatyana   Kane Robert L.   Tuttle Todd M.  

Journal of the National Cancer Institute Monographs, Vol. 2010, Iss. 41, 2010-10 ,pp. : 113-116

Oxford University Press

Access to resources Recommend Favorite

Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening

By Yen M.-F.   Tabar L.   Vitak B.   Smith R.A.   Chen H.-H.   Duffy S.W.  

European Journal of Cancer, Vol. 39, Iss. 12, 2003-08 ,pp. : 1746-1754

Elsevier

Access to resources Recommend Favorite

SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening

By Emdin Stefan   Granstrand Bengt   Ringberg Anita   Sandelin Kerstin   Arnesson Lars-Gunnar   Nordgren Hans   Anderson Harald   Garmo Hans   Holmberg Lars   Wallgren Arne   behalf of the Swedish Breast Cancer Group) (on  

Acta Oncologica, Vol. 45, Iss. 5, 2006-07 ,pp. : 536-543

Informa Healthcare

Access to resources Recommend Favorite

Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast

By Provenzano E.   Hopper J.L.   Giles G.G.   Marr G.   Venter D.J.   Armes J.E.  

European Journal of Cancer, Vol. 39, Iss. 5, 2003-03 ,pp. : 622-630

Elsevier

Access to resources Recommend Favorite